Lewis & Clark Pharmaceuticals is a pioneering brand that specializes in the synthesis, analysis, and early stage development of adenosine receptor-based compounds. Their focus lies specifically on A2A and A2B antagonists, as well as A2A agonists. What sets Lewis & Clark Pharmaceuticals apart is their ability to create proprietary compounds that are not only highly potent and selective but also possess molecular properties that enable enhanced distribution in tissue and penetration of human skin.

This opens up opportunities for innovative therapies that could address a wide range of chronic and underserved diseases. Lewis & Clark Pharmaceuticals offers a diverse range of products and services that cater to various medical conditions. Their lineup includes A2A/A2B antagonists for solid tumors and hematological malignancies, an A2A agonist patch or cream/gel for auto-inflammatory/autoimmune diseases, oral A2B antagonists for conditions like asthma and type 2 diabetes, and unique A2A agonists for specialty indications such as stress imaging, glaucoma, and local pain relief.

With a focus on developing druggable products and an emphasis on de-risking compound development, Lewis & Clark Pharmaceuticals strives to bring novel therapies to market more efficiently. Their dedication to healthcare extends beyond their own brand, as other resources dedicated to healthcare have utilized Lewis & Clark Pharmaceuticals' materials to offer more meaningful prevention and treatment approaches